Lactobacillus rhamnosus GG.

Inulin is a fructan that human enzymes cannot break down, so it arrives in the colon intact and is fermented by lactobacilli. Pairing a live strain with its fermentable substrate is the standard synbiotic design.

GOS is preferentially fermented by lactobacilli and bifidobacteria, which raises lactate and short chain fatty acid output and lowers colonic pH. That shift favours the delivered strain over acid-sensitive residents.

Short chain fructooligosaccharides are fermented by Lactobacillus species to lactate and acetate. Supplying them alongside the strain gives it a carbon source in a competitive environment.

Lactobacilli release lactate that bifidobacteria and butyrate producers consume, so the two genera occupy complementary steps of the same fermentation chain. Multi-strain formulation practice rests on this cross-feeding.

S. boulardii is a yeast, so conditions that suppress bacterial strains leave it untouched and it acts through different surface binding and enzyme routes. Formulators combine the two to keep coverage when one class is knocked back.

Lactoferrin binds free iron, which most gut bacteria need to grow, while lactobacilli have an unusually low iron requirement. Withdrawing free iron therefore tilts the competitive balance toward the delivered strain.

Glutamine is the main fuel of the enterocyte and supports tight junction protein expression, while the strain acts on the same barrier from the luminal side. The two reach normal barrier function from opposite faces of the epithelium.

Butyrate is the preferred energy substrate of colonocytes and is produced downstream of the lactate that lactobacilli generate. Supplying it directly covers that step while the strain establishes.

Colostrum carries immunoglobulins and milk oligosaccharides that lactobacilli ferment. The oligosaccharide fraction acts as a prebiotic while the immunoglobulins bind luminal antigens.

Carvacrol and thymol disrupt bacterial membranes without sparing host-friendly species, so they lower the viable count of a delivered Lactobacillus alongside other organisms. Standard practice is to separate the two by several hours or run them in different phases.

Berberine has direct antibacterial activity across many gut genera, lactobacilli included. Taken in the same dose window it works against the delivered strain rather than with it.

Activated charcoal adsorbs organic molecules in the gut lumen without selectivity. Co-dosing removes substrates the strain depends on and reduces what reaches the colon intact.

Silver ions bind bacterial thiol groups and disrupt membranes without distinguishing resident from delivered organisms. It lowers the viable count of any co-dosed Lactobacillus.

Both are lactic acid producing rods that ferment carbohydrate to lactate and lower luminal pH. Multi-strain blends are the ordinary formulation practice because strains differ in where they adhere and what they ferment. Combining them does not make either colonise permanently; both are transient passengers while dosing continues.

Bifidobacteria occupy the colon while LGG is studied mostly in the small bowel and proximal colon, so the two cover different stretches of the same tract. Bifidobacterial fermentation yields acetate, which butyrate producers use as a substrate. The pairing is additive coverage rather than a demonstrated combined effect.

Both tolerate bile and gastric acid well enough to arrive alive in reasonable numbers, which is the practical bar for an oral strain. Their fermentation profiles overlap but their adhesins differ. Any blend still depends on delivered viable counts at end of shelf life, not on strain list length.

Resistant starch escapes small-intestinal digestion and reaches the colon intact, where it is fermented to short chain fatty acids. LGG itself is a modest butyrate producer, and an animal study reported that it shifts the community toward butyrate production rather than making most of it directly. Feeding the resident community is the mechanism, so the benefit is indirect.

Partially hydrolysed guar gum is a soluble, low-viscosity fermentable fibre that colonic bacteria use as a carbon source. Pairing a fermentable fibre with a live strain is the classic synbiotic construction. The fibre is fermented by resident bacteria as well as the added strain, so the effect is on the whole community.

Pectin is a fermentable soluble fibre that reaches the colon and supports acid-producing fermentation. It also raises viscosity in the upper gut, which slows transit and lengthens contact time. Gas and bloating during the first days of a higher fibre load are the usual trade-off.

Oat beta-glucan is fermented in the colon and raises short chain fatty acid production by the resident community. It is a substrate, not a growth factor specific to LGG. The pairing is common in sachet products because both are stable dry powders.

Psyllium is only partly fermented and works mostly by holding water and normalising stool form. That changes transit time, which changes how long a live strain stays in contact with the mucosa. Take psyllium with enough fluid; taken dry it can bulk before it hydrates.

Native guar gum is highly viscous and fermentable, so it both slows transit and feeds colonic fermentation. The viscosity that makes it useful also makes it gritty in solution at higher doses. Hydrolysed versions trade viscosity for palatability.

Chicory inulin is a fructan that human enzymes cannot cleave, so it arrives in the colon as fermentable substrate. Lactobacilli and bifidobacteria carry the enzymes to use it. People sensitive to fermentable carbohydrates often report more gas at the doses used in synbiotic products.

Zinc is required for epithelial cell turnover and for tight junction protein expression, the same barrier machinery that live strains are studied against. The two act on the barrier from different sides, one nutritional and one microbial. This is a mechanistic pairing, not a tested combination.

Zinc carnosine dissociates slowly at the mucosal surface, which is why it is used where a longer local contact is wanted. Live strains act on the same surface through mucin and tight junction signalling. Neither one has been shown to depend on the other.

The vitamin D receptor is expressed on intestinal epithelium and on immune cells in the lamina propria, and its signalling influences antimicrobial peptide expression. Live strains signal to the same cells through pattern recognition receptors. The overlap is mechanistic; no combination trial grounds a joint effect.

Lactic acid bacteria carry beta-galactosidase, which is the same bond-cleaving activity supplied by a lactase preparation. In practice a supplemental enzyme acts immediately in the small intestine while bacterial activity is slower and partial. People who use both usually do so for dairy-containing meals.

Marshmallow root supplies mucilage polysaccharides with the same coating and fermentable character as other mucilages. The pairing with a live strain rests on tradition and on plausible substrate provision. No combination study supports it.

Protease-containing enzyme blends and live bacteria are commonly capsuled together for convenience. Proteases act on dietary protein in the lumen and there is no evidence they degrade a delivered strain at supplement doses. The combination is a convenience decision, not a synergy with data behind it.

Allicin and its breakdown products have broad antibacterial activity in vitro, and lactic acid bacteria are not exempt from it in a test tube. Whether a culinary or capsule dose reaches the gut at inhibitory concentrations is not established. Separating the doses by a few hours is the cautious approach.

Catechins inhibit some bacteria in culture and are themselves metabolised by gut bacteria into smaller phenolics. The direction of the interaction depends on strain and concentration, and it has not been measured for LGG in people. This is a flag for co-formulation, not a warning.

Layered clays adsorb proteins and microorganisms onto their surfaces by charge interaction. Taken in the same swallow as a live culture, a binder can plausibly reduce how many cells arrive intact. Spacing the two apart costs nothing and removes the question.

Several lactic acid bacteria synthesise B vitamins including riboflavin and folate as part of normal metabolism, and strains differ widely in how much. Colonic synthesis is not the main human source of these vitamins. Regard this as a mechanism of interest rather than a nutritional contribution you can count on.